Delivery Order SPE2DB20D6037-SPE2DB21FC9ZL

Award Date 8/6/21
Potential Completion Date 8/9/21
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,595.10, is a firm fixed-price delivery order for the supply of Erythromycin 0.5% eye ointment. The contract is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $1,326.31 firm fixed-price delivery order is for the supply of Erythromycin Ophthalmic, a prescription eye medication, to support the recurring medical needs of U.S. military health facilities. The award is associated with a larger indefinite delivery contract (IDC) valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,103.80, is for the delivery of Erythromycin 0.5% eye ointment to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,325.60 award is for the delivery of Erythromycin 0.5% eye ointment, 3.5 grams. This order is part of a larger indefinite delivery contract (IDV), contract number SPE2DB24FZR72, with a ceiling value of up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,063.40 contract is for the delivery of Erythromycin 0.5% eye ointment to support the medical supply needs of military health facilities. The contract is issued under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,030.12 contract is for the delivery of Erythromycin Ophthalmic, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,063.40 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of 0.5% erythromycin eye ointment. The contract has a completion date of March 29, 2024 and is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB24FDH61 with DLA, worth up to $4,999,999 through 2025. This larger contract vehicle enables DLA to procure a broad range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,326.31 firm fixed-price contract is for the delivery of Erythromycin Ophthalmic, a prescription antibiotic eye solution. This delivery order is part of a larger single-award indefinite delivery contract (IDC), valued at up to $499,999,999, held by DMS Pharmaceutical Group with the DLA under...
This federal contract award, valued at $1,860.95, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the provision of Erythromycin 0.5% eye ointment to the Department of Defense (DoD) healthcare facilities. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $1,063.40 contract is for the delivery of Erythromycin 0.5% Eye Ointment. This order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, valued up to $4,999,999 through 2025, which enables the agency to place orders for a broad range of...
  • SPE2DB20D6037
    Indefinite Delivery Contract
  • SPE2DB20D6037-SPE2DB21FC9ZL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,330.04 firm fixed-price contract is for the supply of Erythromycin 0.5% eye ointment 3.5g.

The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to the Department of Defense healthcare system.

This contract award does not have a set-aside designation. DMS Pharmaceutical Group's status as a woman-owned small business has allowed the company to secure direct awards for pharmaceutical Prime Vendor programs supporting military medical facilities globally.

Generated 10/23/24, 9:03 AM